Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Control of Cognition: Naltrexone, Methylphenidate, and ADHD Study
NCT01993108Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Oct 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate, naltrexone in attention deficit hyperactivity disorder (ADHD), sponsored by University of Michigan. Started Oct 2013; status: completed.
02
Drugs
methylphenidatenaltrexone
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01993108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993108.